NL-OMON55207招募中不适用
Quality of life research among melanoma patients that have been treated with immunotherapy, or targeted therapy and/or surgery - AILEEN study
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 700 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- At least 18 years of age
- •- Actively treated for melanoma by use of immunotherapy, targeted therapy,
- •surgery or a combination.
- •- Willing to fill in one questionnaire and perform one online cognition test.
排除标准
- •- Insufficient understanding of the Dutch or English language
研究者
相似试验
尚未招募
不适用
Melanoma patients and Quality of Life after active treatmentMelanoma (stage III/IV)NL-OMON26948o sponsors, the study is investigator initiated500
已完成
不适用
Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)Melanoma (Skin) Stage IVRemissionNCT03518814Lille Catholic University40
已完成
不适用
Quality of Life in Patients With Nonmelanoma Skin CancerNonmelanoma Skin CancerNCT00518037Northwestern University112
已完成
不适用
Long-Term Quality of Life in Patients With Metastatic Melanoma Treated With Checkpoint InhibitorsMetastatic MelanomaNCT03326973Memorial Sloan Kettering Cancer Center107
已完成
不适用
Melanoma Patients’ and Clinicians’ Satisfaction with Telehealth During COVID-19Cancer - Malignant melanomaMelanomaACTRN12620001167954Melanoma Institute Australia115